114 related articles for article (PubMed ID: 1478049)
1. Susceptibility testing interpretive criteria and drug stability for cefdinir, cefetamet, and cefpodoxime against Neisseria gonorrhoeae.
Barrett MS; Jones RN
Diagn Microbiol Infect Dis; 1992; 15(8):685-91. PubMed ID: 1478049
[TBL] [Abstract][Full Text] [Related]
2. Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1992; 15(8):693-701. PubMed ID: 1478050
[TBL] [Abstract][Full Text] [Related]
3. MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin.
Erwin ME; Jones RN; Koontz FP; Gerlach EH; Murray PR; Washington JA
J Clin Microbiol; 1992 May; 30(5):1317-9. PubMed ID: 1316371
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.
Bauernfeind A; Jungwirth R
Infection; 1991; 19(5):353-62. PubMed ID: 1800377
[TBL] [Abstract][Full Text] [Related]
5. Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium.
Erwin ME; Jones RN
J Clin Microbiol; 1992 May; 30(5):1170-3. PubMed ID: 1316366
[TBL] [Abstract][Full Text] [Related]
6. Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.
Bale MJ; Jones RN
J Clin Microbiol; 1993 Sep; 31(9):2538-40. PubMed ID: 8408586
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Neisseria gonorrhoeae to cefpodoxime: determination of MICs and disk diffusion zone diameters.
Fekete T; Woodwell J; Cundy KR
Antimicrob Agents Chemother; 1991 Mar; 35(3):497-9. PubMed ID: 1903910
[TBL] [Abstract][Full Text] [Related]
8. Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef.
Biedenbach DJ; Jones RN
J Clin Microbiol; 1994 Feb; 32(2):559-62. PubMed ID: 8150976
[TBL] [Abstract][Full Text] [Related]
9. Interpretive criteria for susceptibility tests with DU-6859a and FK-037 tested against Haemophilus influenzae and Neisseria gonorrhoeae.
Jones RN; Barrett MS; Biedenbach DJ
Diagn Microbiol Infect Dis; 1994 Jun; 19(2):93-9. PubMed ID: 7805362
[TBL] [Abstract][Full Text] [Related]
10. Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline.
Jones RN; Gavan TL; Thornsberry C; Fuchs PC; Gerlach EH; Knapp JS; Murray P; Washington JA
J Clin Microbiol; 1989 Dec; 27(12):2758-66. PubMed ID: 2531756
[TBL] [Abstract][Full Text] [Related]
11. The sensitivity of 173 Sydney isolates of Neisseria gonorrhoeae to cefpodoxime and other antibiotics used to treat gonorrhea.
Tapsall JW; Phillips EA
Pathology; 1995 Jan; 27(1):64-6. PubMed ID: 7603756
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae. Interpretive criteria and comparisons with Etest results.
Jones RN; Barrett MS; Deguchi T
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):193-200. PubMed ID: 9327248
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].
Xiao YH; Gao L; Li Y; Lü Y; Liu J; Liu Y
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1867-71. PubMed ID: 15631795
[TBL] [Abstract][Full Text] [Related]
14. Interpretive criteria for cefodizime in vitro susceptibility tests with Neisseria gonorrhoeae.
Barrett MS; Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1993 Oct; 17(3):243-5. PubMed ID: 8112036
[TBL] [Abstract][Full Text] [Related]
15. Cefpodoxime 10 μg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes.
Limnios A; Tapsall J; Kahlmeter J; Hogan T; Ray S; Lam A; Unemo M
APMIS; 2011 Jun; 119(6):356-63. PubMed ID: 21569093
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir.
Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Dec; 38(12):2902-4. PubMed ID: 7695280
[TBL] [Abstract][Full Text] [Related]
17. [In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
Kawada H; Kitayama A; Fukuoka T; Ishii C; Abe T; Kakuta M; Domon H; Ohya S; Utsui Y
Jpn J Antibiot; 1999 Aug; 52(8):533-40. PubMed ID: 10587878
[TBL] [Abstract][Full Text] [Related]
18. Ceftizoxime interpretive criteria for in vitro susceptibility tests with Neisseria gonorrhoeae.
Barrett MS; Jones RN; Erwin ME
J Clin Microbiol; 1993 Sep; 31(9):2531-2. PubMed ID: 8408583
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to cephalosporins of penicillin-susceptible and penicillin-resistant strains of Neisseria gonorrhoeae from Philadelphia.
Fekete T; Serfass DA; Lafredo SC; Cundy KR
Antimicrob Agents Chemother; 1989 Feb; 33(2):164-6. PubMed ID: 2497703
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibiotic susceptibilities of Neisseria gonorrhoeae isolates in the Philippines.
Clendennen TE; Hames CS; Kees ES; Price FC; Rueppel WJ; Andrada AB; Espinosa GE; Kabrerra G; Wignall FS
Antimicrob Agents Chemother; 1992 Feb; 36(2):277-82. PubMed ID: 1605592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
